Autor/in Bug, G Platzbecker, U 3 Czibere, A 2 Kröger, N 2 Schroeder, T 2 Uharek, L 2 Albrecht, S 1 Altamura, S 1 Bader, P 1 Berg, T 1 Bruns, I 1 Burchert, A 1 Cadeddu, R-P 1 Dienst, A 1 Fenk, R 1 Fröbel, J 1 Germing, U 1 Giagounidis, A 1 Güller, S 1 Hubert, K 1 Hünecke, S 1 Jaekel, N 1 Kröger, Nicolaus 1 Leismann, O 1 Lieder, K 1 Luft, T 1 Metzelder, S K 1 Rieger, K 1 Schetelig, J 1 Stadler, M 1 Wagner, E-M 1 Wolf, A 1 Wolschke, C 1 Zohren, F 1 de Haas, K 1 alle zeigenListe einklappen
Phase I/II study of the deacetylase inhibitor panobinostat after allogeneic stem cell transplantation in patients with high-risk MDS or AML (PANOBEST trial) Bug, G Burchert, A Wagner, E-M Kröger, N Berg, T Güller, S Metzelder, S K 2017 - Forschungsinformationssystem des UKE
Efficacy and safety of deferasirox in non-thalassemic patients with elevated ferritin levels after allogeneic hematopoietic stem cell transplantation Jaekel, N Lieder, K Albrecht, S Leismann, O Hubert, K Bug, G Kröger, Nicolaus 2016 - Forschungsinformationssystem des UKE
Salvage therapy with azacitidine increases regulatory T cells in peripheral blood of patients with AML or MDS and early relapse after allogeneic blood stem cell transplantation Schroeder, T Fröbel, J Cadeddu, R-P Czibere, A Dienst, A Platzbecker, U Bug, G 2013 - Forschungsinformationssystem des UKE
Azacitidine and donor lymphocyte infusions as first salvage therapy for relapse of AML or MDS after allogeneic stem cell transplantation Schroeder, T Czibere, A Platzbecker, U Bug, G Uharek, L Luft, T Giagounidis, A 2013 - Forschungsinformationssystem des UKE
